|
 |
European Pharmaceutical Contractor
|
EPC has a new owner and this is the first edition of any of our three magazines - EPC, EBR and PMPS - that has been produced entirely under the new management of Samedan Ltd. As we go forward into 2002 we confidently believe that all three magazines will go from strength to strength and build on the quality that our readers have come to expect. It is also EPC's fifth anniversary and our 21st issue, with over 400 editorial articles behind us covering an extraordinary range of topics. It is not surprising then that we return to themes that may be familiar to some of our regular readers. But this only emphasises their importance and general interest.
One of these important themes is that of the role of 'electronics' in clinical development. In this issue we have six articles that address this theme. Over the years we have seen a number of articles that have emphasised the promise of electronics in making a major contribution to the speeding up of clinical trials. These articles reinforce the promise, but a promise it remains, and it will be, in my opinion, several years before electronic trials replace the more traditional, albeit slower, methodology. In a related article, Clarke Graham's article on brand protection discusses how the Internet can be both a benefit and a threat by providing global branding reach.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Evolution Summit 2010
27-29 October 2010, Montreux, Switzerland
Amidst attrition challenges and pressures from stakeholders, the laurels are up for grabs for the next leaders in drug development. While the industry is struggling to achieve financial sustainability and operational viability, it is awaiting the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies continue securing long-lasting lucrative partnerships along their value chains. Incorporating novel development paradigms and improving internal decision-making pave the way to shorter timelines and growing profit margins.
More info >> |
|
 |
News and Press Releases |
 |
Almac launch Biomarkers for biopharma
Almac today announced the launch of Biomarkers for biopharma; a range of solutions specifically designed to meet the needs of the biopharma industry. Almac’s solutions are to support biopharma companies in adopting biomarker strategies to enable them to better understand their drug, improve their drug’s success rate, improve the drug’s value and ultimately maximise their drug’s potential.
More info >> |
|
 |
